New Technologies For Application To Veterinary Therapeutics.
Published 2010 · Engineering, Medicine
Download PDFAnalyze on Scholarcy
The purpose of this contribution is to review new technologies and make an educated prediction as to how they will impact veterinary pharmacology over the coming decades. By examining past developments, it becomes evident that change is incremental and predictable unless either a transforming discovery or a change in societal behaviour occurs. In the last century, both discoveries and behaviours have dramatically changed medicine, pharmacology and therapeutics. In this chapter, the potential effects of six transforming technologies on veterinary therapeutics are examined: continued advances in computer technology, microfluidics, nanotechnology, high-throughput screening, control and targeted drug delivery and pharmacogenomics. These should lead to the more efficacious and safer use of existing medicants, and the development of novel drugs across most therapeutic classes through increases in our knowledge base, as well as more efficient drug development. Although this growth in technology portends major advances over the next few decades, economic and regulatory constraints must still be overcome for these new drugs or therapeutic approaches to become common practise.
This paper references
The Human-Animal Bond and Grief
L. Lagoni (1994)
Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model.
J. Buur (2008)
Pharmacometrics : the science of quantitative pharmacology
E. Ette (2007)
Systems Biology: A Brief Overview
H. Kitano (2002)
Large-scale temporal gene expression mapping of central nervous system development.
X. Wen (1998)
Genomics and proteomics: the new millennium of drug discovery and development.
M. J. Cunningham (2000)
Quantification of chemical mixture interactions modulating dermal absorption using a multiple membrane fiber array.
R. Baynes (2008)
PEG drugs: an overview.
R. Greenwald (2001)
Use of Probabilistic Modeling within a Physiologically Based Pharmacokinetic Model To Predict Sulfamethazine Residue Withdrawal Times in Edible Tissues in Swine
J. Buur (2006)
Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model.
H. A. Lee (2009)
Comprar Nanotoxicology: Characterization, Dosing and Health Effects | Nancy A. Monteiro-Riviere | 9781420045147 | Informa Healthcare
N. A. Monteiro-Riviere (2007)
Nanotoxicology : characterization, dosing and health effects
N. Monteiro-Riviere (2007)
An experimentally based approach for predicting skin permeability of chemicals and drugs using a membrane-coated fiber array.
Xin-Rui Xia (2007)
Miniaturized total chemical analysis systems: A novel concept for chemical sensing
A. Manz (1990)
Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators.
Jessica P. Ryman-Rasmussen (2007)
Physiologically Based Pharmacokinetic Modeling
H. Clewell (2010)
Process analytical applications of Raman spectroscopy
J. Rantanen (2007)
Physiologically Based Pharmacokinetic Modeling : Science and Applications
M. Andersen (2005)
Microfluidic arrays for logarithmically perfused embryonic stem cell culture.
Lily Nari Kim (2006)
Drugs on Target
R. Langer (2001)
Patterned cell culture inside microfluidic devices.
S. W. Rhee (2005)
Initiative Aims to Merge Animal and Human Health Science to Benefit Both
M. Enserink (2007)
Pharmacological treatment in behavioural medicine.
S. Mayhew (2001)
Science and applications
The future of veterinary therapeutics: a glimpse towards 2030.
J. Riviere (2007)
Scientific Criteria to Ensure Safe Food: Institute of Medicine, Natural Research Council of the National Academies. The National Academy Press, Washington D.C.; www.nap.edu; xxi+401 pages; soft cover, $35.95; ISBN 0-309-08928-X (hard cover)
N. Skovgaard (2004)
Towards an in vivo biologically inspired nanofactory.
P. LeDuc (2007)
Electrically-Assisted Transdermal Drug Delivery
J. Riviere (2004)
Dirlotapide: a review of its properties and role in the management of obesity in dogs.
J. Wren (2007)
Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening.
Y. Hsieh (2006)
Nanotechnology For Dummies
Earl Boysen (2005)
Light-directed, spatially addressable parallel chemical synthesis.
S. P. Fodor (1991)
Therapeutic implications of the MDR-1 gene.
K. Mealey (2004)
A physiologically based pharmacokinetic model for oxytetracycline residues in sheep.
A. Craigmill (2003)
The environmental food crisis : the environment's role in averting future food crises
C. Nellemann (2009)
Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system.
G. Widera (2006)
Genomics in Drug Discovery and Development
Dimitri Semizarov (2008)
Potential and problems of developing transdermal patches for veterinary applications.
J. Riviere (2001)
Veterinary Pharmacology and Therapeutics
L. M. Jones (1965)
Basic local alignment search tool.
S. Altschul (1990)
Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
M. Schena (1995)
Population pharmacokinetics in veterinary medicine: potential use for therapeutic drug monitoring and prediction of tissue residues.
T. Martín-Jiménez (1998)
Cutaneous gene transfer for skin and systemic diseases
P. Khavari (2002)
Technologies for the control of fat and lean deposition in livestock.
M. Sillence (2004)
Toxicity Testing in the 21st Century: A Vision and a Strategy
D. Krewski (2010)
Pharmacological treatment in behavioural medicine: the importance of neurochemistry, molecular biology and mechanistic hypotheses.
K. Overall (2001)
Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.
F. Verbaan (2007)
Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots.
J. Riviere (2009)
The Evolving Role of Drug Metabolism in Drug Discovery and Development
Lilian G. Yengi (2006)
Microfluidic devices for the high-throughput chemical analysis of cells.
M. A. McClain (2003)
This paper is referenced by
Antinociceptive Effect of Intravenous Regional Analgesia in Horses Underwent Selected Short-Time Distal Limb Surgeries.
A Antony Samy (2020)
Effects of polydimethylsiloxane (PDMS) microchannels on surface acoustic wave-based microfluidic devices
M. C. Jo (2014)
An Acoustic-based Microfluidic Platform for Active Separation and Mixing
Myeong Chan Jo (2013)
Veterinary pharmacology: history, current status and future prospects.
P. Lees (2013)